Circulating MicroRNAs as Biomarkers for Sepsis

Area of Science:

• Biochemistry
• Molecular Biology
• Critical Care Medicine

Background:

• Sepsis is a leading cause of death in intensive care units, with limited treatment options.
• Current diagnostic and prognostic markers for sepsis have limited clinical utility.
• Circulating microRNAs (miRNAs) are emerging as potential biomarkers due to their altered expression in various pathologies.

Purpose of the Study:

• To summarize current findings on circulating miRNAs in sepsis diagnosis and staging.
• To compare human patient data with animal model findings.
• To highlight challenges hindering the clinical application of miRNAs as sepsis biomarkers.

Main Methods:

• Review of array- and single PCR-based studies identifying deregulated miRNAs in sepsis.
• Analysis of correlations between miRNA levels, disease stage, and patient prognosis.
• Comparison of human data with findings from sepsis animal models.

Main Results:

• Several miRNAs (e.g., miR-25, miR-133a, miR-146, miR-150, miR-223) are deregulated in sepsis.
• Some altered miRNAs correlate with sepsis disease stage and patient outcomes.
• Circulating miRNA profiles may differ between human sepsis and animal models.

Conclusions:

• Circulating miRNAs hold promise as diagnostic and prognostic biomarkers for sepsis.
• Translating miRNA findings into clinical practice faces significant challenges.
• Further validation and standardization are crucial for routine clinical use of miRNAs in sepsis management.